Norman David Eansor, President-Protein Sciences at BIO-TECHNE Corp (TECH), sold 15,514 shares at $264.01 ($4.1M) on 2020-05-29, disclosed to the SEC on 2020-06-01.
Open-market sale of $4.1M TECH by President-Protein Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $260.19 | 3,448 | $897K | 22.1% |
| 2 | $260.19 | 3,448 | $897K | 22.1% |
| 3 | $260.83 | 1,700 | $443K | 10.9% |
| 4 | $261.74 | 3,400 | $890K | 22.0% |
| 5 | $262.68 | 2,100 | $552K | 13.6% |
| 6 | $264.01 | 709 |
| $187K |
| 4.6% |
| 7 | $264.01 | 709 | $187K | 4.6% |
| Total | $261.29 avg | 15,514 | $4.1M | 100% |
| Filing → |
| TECH | SELL | 2021-09-02 | $1.5M | — | Filing → |
| TECH | SELL | 2021-02-09 | $17.4M | — | Filing → |
| TECH | SELL | 2020-05-26 | $12.4M | — | Filing → |